CXCL12 and esophageal squamous cell carcinoma: Furthermore, the TE1 and KYSE30 were treated with SDF-1α combined with chemotherapeutic agents (cisplatin) or AMD3100, and the results demonstrate that the SDF-1α/CXCR4 axis suppresses ESCC cell growth (Figure 4).